T
Tung Thanh Le
Publications - 7
Citations - 1950
Tung Thanh Le is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 4 publications receiving 1312 citations.
Papers
More filters
Journal ArticleDOI
The COVID-19 vaccine development landscape.
Tung Thanh Le,Zacharias Andreadakis,Arun Kumar,Raúl Gómez Román,Stig Tollefsen,Melanie Saville,Stephen Mayhew +6 more
TL;DR: The Coalition for Epidemic Preparedness Innovations has developed and is continuously maintaining an overview of the global landscape of COVID-19 vaccine development activity, which includes vaccine development programmes reported through the WHO's authoritative and continually updated list, along with other projects identified from publicly available and proprietary sources.
Journal ArticleDOI
Evolution of the COVID-19 vaccine development landscape
TL;DR: Una rápida propagación a escala comunitaria, regional e internacional, con un aumento exponencial del número de casos y muertes de COVID-19 se ha propagado a todos los 54 países y territorios de the Región de las Américas.
Journal ArticleDOI
Status Report on COVID-19 Vaccines Development
Arun Kumar,William E Dowling,Raúl Gómez Román,Amol Chaudhari,Céline Gurry,Tung Thanh Le,Stig Tollefson,Carolyn Clark,Valentina Bernasconi,Paul A. Kristiansen +9 more
TL;DR: In this article, the authors summarized novel and traditional approaches for COVID-19 vaccine development including inactivated, attenuated, nucleic acid, vector and protein based, and showed comparative immunogenicity profiles of various vaccines in clinical phases.
Journal ArticleDOI
The mRNA vaccine development landscape for infectious diseases
Journal ArticleDOI
Medical countermeasures against henipaviruses: a review and public health perspective.
Raúl Gómez Román,Nadia Tornieporth,Neil George Cherian,Amy C. Shurtleff,Maïna L’Azou Jackson,Debra Yeskey,Adam Hacker,Eric Mungai,Tung Thanh Le +8 more
TL;DR: In this article, the authors review the evidence of medical countermeasures against henipaviruses and project their cost in a post-COVID-19 era, given the sporadic and unpredictable nature of the Nipah virus outbreaks.